Comparing keyhole and open surgery to remove a kidney, including costs
Compares laparoscopic and open kidney removal in people with kidney cancer or a non-working kidney.
Plain-language title generated from the registry record
Registry title: Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
Key facts
- Where
- Shibīn al Kawm, EgyptSee the site
Where in Egypt
- Menoufia Faculty of MedicineShibīn al Kawm, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Menoufia University
- Trial code
- NCT07461090
- Record updated
- 11 March 2026
- Original description
To evaluate and compare clinical effectiveness (operative time, blood loss, hospital stay, complications and etc) and cost analysis' between laparoscopic nephrectomy and open nephrectomy .Read full original descriptionShow less
Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
To evaluate and compare clinical effectiveness (operative time, blood loss, hospital stay, complications and etc) and cost analysis' between laparoscopic nephrectomy and open nephrectomy .
Inclusion: American Society of Anesthesiology score 1-3; Indication for :; Simple total nephrectomy or hemi nephrectomy: benign chronic inflammatory non-functioning kidney; Partial nephrectomy: localized renal mass ≤7 cm suitable for nephron-sparing surgery; Radical nephrectomy or Radical nephrouretrectomy with bladder cuff: localized renal tumor requiring complete nephrectomy without major vascular invasion; Patient deemed fit for general anesthesia and surgery; Patient provides written informed consent.
Exclusion: emergency surgery, dialysis-dependent patients, planned hybrid procedures; Prior extensive ipsilateral retroperitoneal surgery or severe adhesions precluding Laparoscopy; Need for concomitant major procedures (eg, large bowel resection) at index operation; Patients with metastatic disease at presentation; Patients with incomplete data; Locally advanced tumor with obvious major vascular involvement requiring complex vascular reconstruction; Uncorrected coagulopathy; Pregnancy or Obese patient (BMI > 40); Inability to provide informed consent or comply with follow-up.